With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

With the holidays past and the new year arrived, we look ahead — to losing weight. For some that resolve theoretically ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...

"We see opportunity within our unique snacking portfolio," Tom McGough, co‐chief operating officer with Conagra Brands, told ...

Six out of 31 total new small molecules approved by the FDA in 2024 were produced by Wuxi, said the company's co-CEO.

The most negatively impacted sectors are frozen, refrigerated, general food and beverages. Circana found GLP-1 users’ monthly ...

Glucagon-like peptide-1 (GLP-1) analogs also known as incretin mimetics are class of drugs indicated for type-2 diabetes mellitus to lower the blood sugar level Mr. Shah Coherent Market Insights Pvt.

A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...

Patients with obesity and comorbid cardiovascular disease were more likely to ration prescription drugs than those without obesity.

Eli Lilly's experimental weight loss drug, retatrutide, has demonstrated encouraging results in helping obese adults lose weight.